A new frontier in the treatment of cancer: NK-1 receptor antagonists

Current Medicinal Chemistry

Volumn 17, Issue 6, 2010, Pages 504-516

  Munoz M ^a   Rosso, M ^a   Covenas R ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Antitumour; Cancer; Drug; Metastasis; Neoangiogenesis; NK 1 receptor; NK 1 receptor antagonists; Substance P

Indexed keywords

APREPITANT; CJ 11 974; CP 122 721; CP 96 345; CP 99 994; EZLOPITANT; L 732 138; L 733 060; MEN 11 149; MEN 11 467; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; PLACEBO; RP 67 580; SUBSTANCE P; UNCLASSIFIED DRUG; VINBLASTINE; VOFOPITANT;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CYTOTOXICITY; DEPRESSION; DRUG BIOAVAILABILITY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TARGETING; HUMAN; IC 50; INFLAMMATORY DISEASE; METASTASIS; MITOGENESIS; NONHUMAN; RECEPTOR UPREGULATION; REVIEW; VOMITING;

ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 77950639335     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790416308     Document Type: Review

References (124)

1. Luo, W.; Sharif, T.R.; Sharif, M. Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res., 1996, 56, 4983-4991 (Pubitemid 26374439)
2. Muñoz, M.; Pérez, A.; Rosso, M.; Zamarriego, C.; Rosso, R. Antitumoural action of NK-1 receptor antagonist L-733,060 on human melanoma cell lines. Melanoma Res., 2004, 14, 183-188 (Pubitemid 38879579)
3. Muñoz, M.; Rosso, M.; Pérez, A.; Coveñas, R.; Rosso, R.; Zamarriego, C.; Piruat, J.I. The NK-1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides, 2005, 39, 427-432 (Pubitemid 41073623)
4. Muñoz, M.; Rosso, M.; Pérez, A.; Coveñas, R.; Rosso, R.; Zamarriego, C.; Soult, J.A.; Montero, I. Antitumoural action of the neurokinin- 1- receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines. Invest. Ophthalmol. Vis. Sci., 2005, 46, 2567-2570 (Pubitemid 43119507)
5. Muñoz, M.; Rosso, M.; Coveñas, R. The NK-1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on human pancreatic cancer cell lines. Lett. Drug Des. Discov., 2006, 3, 323-329 (Pubitemid 43988115)
6. Muñoz, M.; Rosso, M.; Coveñas, R. In Focus on Neuroblastoma Research, Fernandes, Ed.; Nova Science Publishers: New York, 2007; pp 31-56.
7. Muñoz, M.; Rosso, M.; Aguilar, F.J. ; González-Moles M.A.; Redondo, M.; Esteban, F. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Investig. New Drugs, 2008, 26, 111-118
8. Rosso, M.; Robles-Frias, M.J.; Coveñas, R.; Salinas-Martín, M.V.; Muñoz, M. The NK-1 receptor is involved in the antitumor action of L-733,060 and in the mitogenic action of substance P on human gastrointestinal cancer cell lines. Tumor Biol., 2008, 29, 245-254
9. Payan, D.G.; Brewster, D.R.; Goetzl, E.J. Specific stimulation of human T lymphocytes by substance P. J. Immunol., 1983, 131, 1613-1615 (Pubitemid 13010122)
10. Nilsson, J.; von Euler, A.M.; Dalsgaard, C.J. Stimulation of connective tissue cell growth by substance P and substance K. Nature, 1985, 315, 61-63 (Pubitemid 15064899)
11. Lotz, M.; Carson, D.A.; Vaughan, J.H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science, 1987, 235, 893-895
12. Ziche, M.; Morbidelli, L.; Pacini, M.; Dolara, P.; Maggi, C.A. NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins. Br. J. Pharmacol., 1990, 100, 11-14
13. Hennig, I.M.; Laissue, J.A.; Horisberger, U.; Reubi, J.C. Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int. J. Cancer., 1995, 61, 786-792
14. Singh, D.; Joshi, D.D.; Hameed, M.; Qian, J.; Gascon, P.; Maloof, P.B.; Mosenthal, A.; Rameshwar, P. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc. Natl. Acad. Sci. USA, 2000, 97, 388-393 (Pubitemid 30055841)
15. Friess, H.; Zhu, Z.; Liard, V.; Shi, X.; Shrikhande, S.V.; Wang, L.; Lieb, K.; Korc, M.; Palma, C.; Zimmermann, A.; Reubi, J.C.; Buchler, M.W. Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab. Invest., 2003, 83, 731-742 (Pubitemid 36618051)
16. Muñoz, M.; Pérez, A.; Coveñas, R.; Rosso, M.; Castro, E. Antitumoural action of L-733,060 on neuroblastoma and glioma cell lines. Arch. Ital. Biol., 2004, 142, 105-112 (Pubitemid 38691234)
17. Muñoz, M.; Rosso, M.; Soult, J.A.; Coveñas, R. In Brain Cancer: Therapy and Surgical Intervention, Yang, Ed.; Nova Science Publishers: New York, 2006; pp 45-75.
18. Muñoz, M.; Rosso, M.; Coveñas, R.; Montero, I.; González-Moles, M.A.; Robles, M.J. Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138. Invest. Ophthalmol. Vis. Sci., 2007, 48, 2775-2781 (Pubitemid 351261233)
19. Akazawa, T.; Kwatra, S.G.; Goldsmith, L.E.; Richardson, M.D.; Cox. E.A.; Sampom, J.H.; Kwatra, M.M. A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas. J. Neurochem., 2009, 109, 1079-1086
20. Lazarczyk, M.; Matyja, E.; Lipkowski, A. Substance P and its receptors - a potential target for novel medicines in malignant brain tumour therapies. Folia Neuropathol., 2007, 45, 99-107.
21. Muñoz, M.; Rosso, M. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Invest. New Drugs., 2009, doi: 10.1007/s10637-009-9218-8.
22. Palma, C.; Bigioni, M.; Irrissuto, C.; Nardelli, F.; Maggi, C.A.; Manzini, S. Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft. Br. J. Cancer, 2000, 82, 480-487 (Pubitemid 30045401)
23. Bigioni, M.; Benzo, A.; Irrissuto, C.; Maggi, C.A.; Goso, C. Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231. Anticancer Drugs, 2005, 16, 1083-1089 (Pubitemid 41565774)
24. Prasad, S.; Mathur, A.; Jaggi, M.; Singh, A.T.; Mukherjee, R. Substance P analogs containing alpha-dialkylated amino acids with potent anticancer activity. J. Pept. Sci., 2007, 13, 544-548 (Pubitemid 47322354)
25. Cuello, AC.; Kanazawa, I. The distribution of substance P immunoreactive fibres in the rat central nervous system. J. Comp. Neurol., 1978, 178, 129-156 (Pubitemid 8374096)
26. Hökfelt, T.; Pernow, B.; Nilsson, G.; Wetterberg, L.; Goldstein, M.; Jeffcoate, S.L. Dense plexus of substance P-immunoreactive nerve terminals in eminentia medialis of the primate hypothalamus. Proc. Natl. Acad. Sci. USA., 1978, 74, 1013-1015 (Pubitemid 8298503)
27. Mai, J.K.; Stephens, P.H.; Hopf, A.; Cuello, A.C. Substance P in the human brain. Neuroscience, 1986, 17, 709-739
28. Burgos, C.; Aguirre, J.A.; Alonso, J.R.; Coveñas, R. Immunocytochemical study of substance P-like fibres and cell bodies in the cat diencephalon. J. Hirnforsch., 1988, 29, 651-657 (Pubitemid 19046442)
29. Cho, K.J.; Trzaska, K.A., Greco, S.J.; McArdle, J.; Wang, F.S.; Ye, J.H.; Rameshwar, P. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells, 2005, 23, 383-391, (Pubitemid 40404457)
30. Kawada, H.; Takizawa, S.; Takanashi, T.; Morita, Y.; Fujita, J.; Fukuda, K.; Takagi, S.; Okano, H.; Ando, K.; Hotta, T. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation, 2006, 113, 701-710 (Pubitemid 43754334)
31. Park, S.W.; Yan, Y.P.; Satriotomo, I.; Vemuganti, R.; Dempsey, R.J. Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J. Neurosurg., 2007, 107, 593-599
32. Turner, A.J. Endopeptidase-24.11 and neuropeptide metabolism. In Neuropeptides and Their Peptidases. Turner, Ed.; Ellis Horwood: Chichester, 1987; pp. 183-201.
33. von Euler, U.S. ; Gaddum, J.H. An unidentified depressor substance in certain tissue extracts. J. Physiol., 1931, 72, 74-87.
34. Pernow, B. Substance P. Pharmacol. Rev., 1983, 35, 85-141.
35. Hökfelt, T.; Pernow, B.; Wahren, J. Substance P: a pioneer amongst neuropeptides. J. Intern. Med., 2001, 249, 27-40.
36. Unger, T.; Rascher, W.; Schuster, C.; Pavlovitch, R.; Schömig, A.; Dietz, R.; Ganten, D. Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. Eur. J. Pharmacol., 1981, 71, 33-42. (Pubitemid 11112563)
37. Hershey, A.D.; Polenzani, L.; Woodward, R.M.; Miledi, R.; Krause, J.E. Molecular and genetic characterization, functional expression, and mRNA expression patterns of a rat substance P receptor. Ann. NY Acad. Sci., 1991, 632, 63-78.
38. Quartara, L.; Maggi, C.A. The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides, 1998, 32, 1-49.
39. Rupniak, N.M.; Carlson, E.; Boyce, S.; Webb, J.K.; Hill, R.G. Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils. Pain, 1996, 67, 189-195
40. Kramer, M.S.; Cutler, N.; Feighner, J.; Shrivastava, R.; Carman, J.; Sramek, J.J.; Reines, S.A.; Liu, G.; Snavely, D.; Wyatt-Knowles, E.; Halle, J.J.; Mills, S.G.; MacCoss, M.; Swain, C.J.; Harrison, T.; Hill, R.G.; Hefti, F.; Scolnick, E.M.; Cascieri, M.A.; Chicchi, G.G.; Sadowski, S.; Williams, A.R.; Hewson, L.; Smith, D.; Carlsson, E.J.; Hargreaves, R.J.; Rupniak, N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science, 1998, 281, 1640-1645
41. Samsam, M.; Coveñas, R.; Ahangari, R.; Yajeya, J.; Narváez, J.A.; Tramu, G. Simultaneous depletion of neurokinin A, substance P and calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat during electrical stimulation of the trigeminal ganglion. Pain, 2000, 84, 389-395 (Pubitemid 30074242)
42. Harrison, S.; Geppetti, P. Substance P. Int. J. Biochem. Cell Biol., 2001, 33, 555-576
43. Bang, R.; Sass, G.; Kiemer, A.K.; Vollmar, A.M.; Neuhuber, W.L.; Tiegs, G. Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury. J. Pharmacol. Exp. Ther., 2003, 305, 31-39 (Pubitemid 36373833)
44. Varty, G.B.; Cohen-Williams, M.E.; Hunter, J.C. The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test. Behav. Pharmacol., 2003, 14, 87-95.
45. Schratzberger, P.; Reinisch, N.; Prodinger, W.M.; Kahler, C.M.; Sitte, B.A.; Bellmann, R.; Fischer-Colbrie, R.; Winkler, H.; Wiedermann C.J. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J. Immunol., 1997, 158, 3895-3901 (Pubitemid 127488749)
46. Ruff, M.R.; Wahl, S.M.; Pert, C.B. Substance P receptor-mediated chemotaxis of human monocytes. Peptides, 1985, 6, 107-111 (Pubitemid 16211115)
47. Dunzendorfer, S.; Meierhofer, C.; Wiedermann, C.J. Signaling in neuropeptide-induced migration of human eosinophils J. Leukocyte Biol., 1998, 64, 828-834
48. Feistritzer, C.; Clausen, J.; Sturn, D.H.; Djanani, A.; Gunsilius, E.; Wiedermann, C.J.; Kahler, C M. Natural killer cell functions mediated by the neuropeptide substance P. Regul. Pept., 2003, 116, 119-126
49. Meshki, J.; Douglas, S.D.; Lai, J.P.; Schwartz, L.; Kilpatrick, L.E.; Tuluc, F. Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinasedependent mechanism. J. Biol. Chem., 2009, 284, 9280-9289
50. Fackler, O.T.; Grosse, R. Cell motility through plasma membrane blebbing. J. Cell Biol., 2008, 181, 879-884 (Pubitemid 351846821)
51. Janelsins, B.M.; Mathers, A.R.; Tkacheva, O.A.; Erdos, G.; Shufesky, W.J; Morelli, A.E.; Larregina, A.T. Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood, 2009, 113, 3017-3026
52. Quartara, L.; Maggi, C.A. The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides, 1997, 31, 537-563
53. MacDonald, S.G.; Boyd, N.D. Regulation of substance P receptor affinity by guanine nucleotide binding proteins. J. Neurochem., 1989, 53, 264-272 (Pubitemid 19158138)
54. Wolf, S.S.; Moody, T.W.; Quirion, R.; O'Donahue, T.L. Biochemical characterization and autoradiographic localization of central SP receptor using [125I] physalaemin. Brain Res., 1985, 332, 299-307.
55. Dam, T.V.; Quirion, R. Pharmacological characterization and autoradiographic characterization of substance P receptors in guinea-pig brain. Peptides, 1986, 7, 855-864 (Pubitemid 17182354)
56. Danks, J.A.; Rothman, R.B.; Cascieri, M.A.; Chicchi, G.G.; Liang, T.; Herkenham, M. A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain. Brain Res., 1986, 385, 273-281 (Pubitemid 16006841)
57. Saffroy, M.; Beaujouan, J.C.; Torrens, Y.; Besseyre, J.; Bergstrom, L.; Glowinski, J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides, 1988, 9, 227-241
58. Maeno, H.; Kiyama, H.; Tohyama, M. Distribution of the substance P (NK1) receptor in the central nervous system. Mol. Brain Res., 1993, 18, 43-58. (Pubitemid 23100236)
59. Nakaya, Y.; Kaneko, T.; Shigemoto, R.; Nakanishi, S.; Mizuno, N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol., 1994, 347, 249-274 (Pubitemid 24273427)
60. Whitty, C.J.; Walker, P.D.; Goebel, D.J.; Poosch, M.S.; Bannon, M.J. Quantitation, cellular localization and regulation of neurokinin receptor gene expression whithin the rat substantia nigra. Neuroscience, 1995, 64, 419-425
61. Almeida, T.; Rojo, J.; Nieto, P.M. Tachykinins and tachykinin receptor: structure and activity relationships. Curr. Med. Chem., 2004, 11, 763-771
62. Shrestha, P.; Yang, L.; Liu, B.; Namba, M.; Takagi, H.; Hosaka, M.; Mori, M. Neuroblastoma of parotid gland: report of a case and immunohistochemical characteristics. Eur. J. Cancer B Oral Oncol., 1994, 30, 356-361 (Pubitemid 24309219)
63. Nowicki, M.; Miskowiak, B. Comparison of the cell immunophenotype of metastatic and primary foci in stage IV-S neuroblastoma. Folia Histochem. Cytobiol., 2002, 40, 297-303. (Pubitemid 34830563)
64. Palma, C.; Nardelli, F.; Manzini, S.; Maggi, C.A. Substance P activates responses correlated with tumour growth in human glioma cells line bearing tachykinin NK1 receptors. Br. J. Cancer., 1999, 79, 236-243
65. Tarkkanen, A.; Tervo, T.; Tervo, K.; Eranko, L.; Eranko, O.; Cuello, A.C. Substance P immunoreactivity in normal human retina and in retinoblastoma. Ophthalmic. Res., 1983, 15, 300-306
66. Khare, V.K.; Albino, A.P.; Reed, J.A. The neuropeptide/mast cell secretagogue substance P is expressed in cutaneus melanocytic lesions. J. Cutan. Pathol., 1998, 25, 2-10.
67. Esteban, F.; González-Moles, M.A.; Castro, D.; Martín-Jaén, M.M.; Redondo, M.; Ruíz-Avila, I.; Muñoz, M. Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression. Histopathology, 2009, 54, 258-260
68. Payan, D.G.; McGillis, J.P.; Organist, M.L. Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P. J. Biol. Chem., 1986, 261, 14321-14329
69. Fowler, C.J.; Brannstrom, G. Substance P enhances forskolinstimulated cyclic AMP production in human UC11MG astrocytoma cells. Methods Find. Exp. Clin. Pharmacol., 1994, 16, 21-28 (Pubitemid 24067672)
70. Johnson, C.L.; Johnson, C.G.; Stauderman, K.A.; Buck, S.H. Characterization of substance P receptors in human astrocytoma cells. Ann. N.Y. Acad. Sci., 1991, 632, 410-412
71. Kast, R.E. Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblatoma growth: a new hypothesis to an old question. Clin. Transl. Oncol., 2009, 11, 408-410
72. Goso, C.; Potier, E.; Manzini, S.; Szallasi, A. Comparison of tachykinin NK1 receptors in human IM9 and U373 MG cells, using antagonist (FK888, (+/-)-CP-96,345, and RP 67580) binding. Eur. J. Pharmacol., 1994, 254, 221-227 (Pubitemid 24098557)
73. Caberlotto, L.; Hurd, Y.L.; Murdock, P.; Wahlin, J.P.; Melotto, S.; Corsi, M.; Carletti, R. Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur. J. Neurosci., 2003, 17, 1736-1746 (Pubitemid 36645323)
74. McGillis, J.P.; Mitsuhashi, M.; Payan, D.G. Immunomodulation by tachykinin neuropeptides. Ann. NY Acad. Sci., 1990, 594, 85-94.
75. Organist, M.L.; Harvey, J.P.; McGillis, J.P.; Payan, D.G. Processing of the human IM-9 lymphoblast substance P receptor. Biosynthetic and degradation studies using a monoclonal anti-receptor antibody. Biochem. Biophys. Res. Commun., 1988, 151, 535-541
76. van Ginkel, F.W.; Pascual, D.W. Recognition of neurokinin 1 receptor (NK1-R): an antibody to a peptide sequence from the third extracellular region binds to brain NK1-R. J. Neuroimmunol., 1996, 67, 49-58.
77. Nakata, Y.; Hiraoka, C.; Segawa, T. Apparent molecular weight of the substance P binding site in rat brain. Eur. J. Pharmacol., 1988, 152, 171-174
78. Mitsuhashi, M.; Ohashi, Y.; Schichijo, S.; Christian, C.; Sudduth-Klinger, J.; Harrowe, G.; Payan, D.G. Multiple intracellular signalling pathways of the neuropeptide SP receptor. J. Neurosci. Res., 1992, 32, 437-443
79. Nakajima, Y.; Tsuchida, K.; Negishi, M.; Ito, S.; Nakanishi, S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cAMP cascades in transfected Chinese hamster ovary cells. J. Biol. Chem., 1992, 267, 2437-2442
80. Takeda, Y.; Blount, P.; Sachais, B.S.; Hershey, A.D.; Raddatz, R.; Krause, J.E. Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1, 4, 5-triphosphate and cyclic AMP second messenger responses. J. Neurochem., 1992, 59, 740-745
81. Seabrook, G.R.; Fong, T.M. Thapsigargin blocks the mobilization of intracellular calcium caused by activation of human NK1 (long) receptors expressed in Chinese hamster ovary cells. Neurosci. Lett., 1993, 152, 9-12.
82. García, M.; Sakamoto, K.; Shigekawa, M.; Nakanishi, S.; Ito, S. Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptor. Biochem. Pharmacol., 1994, 48, 1735-1741 (Pubitemid 24338999)
83. Mochizuki-Oda, N.; Nakajima, Y.; Nakanishi, S.; Ito, S. Characterization of the substance P receptor-mediated calcium influx in cDNA transfected Chinese hamster ovary cells. J. Biol. Chem., 1994; 269, 9651-9658
84. Oury-Donat, F.; Lefevre, I.A.; Thurneyssen, O.; Gauthier, T.; Bordey, A.; Feltz, P.; Edmonds-Alt, X.; Le Fur, G.; Soubrie, P. SR 140,333, a novel, selective, and potent non-peptide antagonist of the NK1 tachykinin receptor: characterization on the U373 MG cell line. J. Neurochem., 1994, 62, 1399-1407. (Pubitemid 24098089)
85. Castagliuolo I., Valenick L., Liu J.; Pothoulakis C. Epidermal growth factor receptor transactivation mediates substance Pinduced mitogenic responses in U-373 MG cells. J. Biol. Chem., 2000, 275, 26545-26550
86. Cheng, J.Q.; Altomare, D.A.; Klein, M.A.; Lee, W.C.; Kruh, G.D.; Lissy, N.A.; Testa, J.R. Transforming activity and mitosisrelated expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene, 1997, 14, 2793-2801
87. Dudek, H.; Datta, S.R.; Franke, T.F.; Birnbaum, M.J.; Yao, R.; Cooper, G.M.; Segal, R.A.; Kaplan, D.R.; Greenberg, M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 1997, 275, 661-665 (Pubitemid 27061332)
88. Bowden, J.J.; Garland, A.M.; Baluk, P.; Lefevre, P.; Grady, E.F.; Vigna, S.R.; Bunnett, N.W.; McDonald, D.M. Direct observation of substance P-induced internalization of NK1 receptors at sites of inflammation. Proc. Natl. Acad. Sci. USA., 1994, 91, 8964-8968
89. Garlan, A.M.; Grady, E.F.; Payan, D.G.; Vigna, S.R.; Bunnett, N.W. Agonist induced internalization of the substance P (NK1) receptor expressed in epithelial cells. Biochem. J., 1994, 303, 177-186
90. Grady, E.F.; Garland, A.M.; Gamp, P.D.; Lovett, M.; Payan, D.G.; Bunnett, N.W. Delineation of the endocytic pathway of substance P and its seven transmembrane domains NK1 receptor. Mol. Biol. Cell., 1995, 6, 509-524
91. Mantyh, P.W.; Allen, C.J.; Ghilardi, J.R.; Rogers, S.D.; Mantyh, C.R.; Liu, H.; Basbaum, A.I.; Vigna, S.R.; Maggio, J.E. Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc. Natl. Acad. Sci. USA., 1995, 92, 2622-2626
92. Sharif, T.R.; Luo, W.; Houghron, P.J.; Sharif, M. Substance K peptide induces mitogenesis by activating the mitogen-activated protein kinase signalling pathway through the substance P receptor (NK-1 subtype) in human astrocytoma. Cell Pharmacol., 1996, 3, 441-449
93. Muñoz, M.; Rosso, M.; Robles-Frías, M.J.; Coveñas, R.; Salinas-Martín, M.V. In Eye Cancer Research Progress, Bospene, Ed.; Nova Science Publishers: New York, 2008; pp. 157-178
94. Cyr, C.; South, V.; Saltzman, A.; Felder, S.; Ricca, G.A.; Jaye, M.; Huebner, K.; Kagan, J.; Croce, C.M.; Schlessinger, J.; Kris, R.M. Cloning, expression of the human substance K receptor, and analysis of its role in mitogenesis. Ann. NY Acad. Sci., 1991, 632, 426-427
95. Hammond, P.J.; Smith, D.M.; Akinsanya, K.O.; Mufti, W.A.; Wynick, D.; Bloom, S.R. Signalling patways mediating secretory and mitogenic responses to galanin and pituitary adenylate cyclaseactivating polypeptide in the 235-1 clonal rat lactotroph cell line. J. Neuroendocrinol., 1996, 8, 457-464
96. Lee, C.M.; Kum, W.; Cockram, C.S.; Teoh, R.; Young, J.D. Functional substance P receptors on a human astrocytoma cell line (U-373 MG). Brain Res., 1989, 488, 328-331 (Pubitemid 19136818)
97. Eistetter, H.R.; Mills, A.; Brewster, R.; Alouani, S.; Rambosson, C.; Kawashima, E. Functional characterization of neurokinin-1 receptors on human U373MG astrocytoma cells. Glia, 1992, 6, 89-95.
98. DeFea, K.A.; Vaughn, Z.D.; O'Bryan, E.M.; Nishijima, D.; Dery, O.; Bunnett, N.W: The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestindependent scaffolding complex. Proc. Natl. Acad. Sci. USA, 2000, 97, 11086-11091
99. Ziche, M.; Morbidelli, L.; Pacini, M.; Geppetti, P.; Alessandri, G.; Maggi, C.A. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc. Res., 1990, 40, 264-278 (Pubitemid 20327679)
100. Sporn, M.B. The war on cancer. Lancet, 1996, 347, 1377-1381
101. Entschladen, F.; Lang, K.; Drell, T.L.; Joseph, J.; Zaenker, K.S. Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol. Immunother., 2002, 51, 467-482
102. Lang, K.; Drell, T.L.; Lindecke, A.; Niggemann, B.; Kaltschmidt, C.; Zaenker, K.S.; Entschladen, F. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int. J. Cancer, 2004, 112, 231-238 (Pubitemid 39244363)
103. Giardina, G.A.M.; Gagliardi, S.; Martinelli, M. Antagonists at the neurokinin receptors-recent patent literature. Drugs, 2003, 6, 758-772 (Pubitemid 37086786)
104. Lee, C.M.; Campbell, N.J.; Williams, B.J.; Iversen, L.L. Molecular characterization of a functional cDNA for rat receptor. Eur. J. Pharmacol., 1986, 130, 209-217
105. Quartara, L.; Altamura, M. Tachykinin receptors antagonists: from research to clinic. Curr. Drug Targets, 2006, 7, 975-992 (Pubitemid 44227581)
106. Snider, R.M.; Constantine, J.W.; Lowwe, I.J. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science, 1991, 251, 435-437 (Pubitemid 21916907)
107. Harrison, T.; Williams, B.J.; Swain, C.J.; Ball, R.G. Piperidineether based hNK1 antagonists 1: determination of the relative and absolute stereochemical requirements. Biomed. Chem. Lett., 1994, 4, 2545-2550
108. Rupniak, N.M.; Carlson, E.C.; Harrison, T.; Oates, B.; Seward, E.; Owen, S.; de Felipe, C.; Hunt, S.; Wheeldon, A. Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology, 2000, 39, 1413-1421 (Pubitemid 30249203)
109. Humphrey, J.M. Medicinal chemistry of selective neurokinin-1 antagonists. Curr. Top. Med. Chem., 2003, 3, 1423-1435
110. Tattersall, F.D.; Rycroft, W.; Cumberbatch, M.; Mason, G.; Tye, S.; Williamson, D.J.; Hale J.J.; Mills, S.G.; Finke, P.E.; MacCoss, M.; Sadowski, S.; Ber, E.; Cascieri, M.; Hill, R.G.; MacIntyre, D.E.; Hargreaves, R.J. The novel NK-1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Neuropharmacology, 2000, 39, 652-663
111. Navari, R.M. Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Expert Opin. Invest. Drug, 2007, 16, 1977-1985 (Pubitemid 351403728)
112. MacLeod, A.M.; Merchant, K.J.; Brookfield, F.; Kelleher, F.; Stevenson, G.; Owens, A.P.; Swain, C.J.; Cascieri, M.A.; Sadowski, S.; Ber, E.; Strader, C.D.; Fong, T.M. Identification of Ltryptophan derivatives with potent and selective antagonist activity at the NK1 receptor. J. Med. Chem., 1994, 37, 1269-1274 (Pubitemid 24179468)
113. Cascieri, M.A.; MacLeod, A.M.; Underwood, D.; Shiao, L.L.; Ber, E.; Sadowski, S.; Yu, H.; Merchant, K.J.; Swain, C.J.; Strader, C.D.; Fong, T.M. Characterization of the interaction of N-acyl-Ltryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor. J. Biol. Chem., 1994, 269, 6587-6591
114. Cahill, C.M.; Coderre, T.J. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain, 2002, 95, 277-285 (Pubitemid 34142651)
115. Woll, P.J.; Rozengurt E. [D-Arg1-D-Phe5, D-Trp7, 9, Leu11] Substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro. Proc. Natl. Acad. Sci. USA., 1988, 35, 1859-1863
116. Esteban, F.; Muñoz, M.; González-Moles, M.A.; Rosso, M. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metast. Rev., 2006, 25, 137-145 (Pubitemid 43723988)
117. Reeve, J.G.; Bleehen, N.M. [D-Arg1-D-Phe5, D-Trp7, 9, Leu11] Substance P induces apoptosis in lung cancer cell lines in vitro. Biochem. Bioph. Res. Commun., 1994, 199, 1313-1319
118. Rosati, R.; Adil, M.R.; Ali, M.A.; Eliason, J.; Orosz, A.; Sebestye, N.F.; Kalemkerian, G.P. Induction of apoptosis by a short-chain neuropeptide analog in small cell lung cancer-stimulation of multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Peptides, 1998, 19, 1519-1523
119. McDonald P.R. Identification of novel potential cancer therapies by synthetic lethal screening. University of Pittsburgh 2008, etd.library.pitt.edu/ .../McDonald Peter DISSERTATION3.pdf
120. Guha, S.; Eibl, G.; Kisfalvi, K.; Fan, R.S.; Burdick, M.; Reber, H.; Hines, O.J.; Strieter, R.; Rozengurt, E. Broad-spectrum G protein- coupled receptor antagonist, [D-Arg1,DTrp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res., 2005; 65, 2738-2745 (Pubitemid 40490075)
121. Exadaktylos, A.K.; Buggy, D.J.; Moriarty, D.C.; Mascha, E.; Sessler, D.I. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology, 2006, 105, 660-664
122. Bolay, H.; Reuter, U.; Dunn, A.K.; Huang, Z.; Boas, D,A.; Moskowitz, M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med., 2002, 8, 136-142
123. Diemunsch, P.; Grelot, L. Potential of substance P antagonists as antiemetics. Drugs, 2000, 60, 533-546
124. Yu, J.; Cadet, J.L.; Angulo, J.A. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J. Neurochem., 2002, 83, 613-622